Effective salvagae therapy for lymphoma with cisplatin in combination with high-dose ara-C and dexamethasone (DHAP)

Blood

Volumn 71, Issue 1, 1988, Pages 117-122

  Velasquez, W S ^a   Cabanillas, F ^a   Salvador, P ^a   McLaughlin, P ^a   Fridrik, M ^a   Tucker, S ^a   Jagannath, S ^a   Hagemeister, F B ^a   Redman, J R ^a   Swan, F ^a   Barlogie, B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYTARABINE; DEXAMETHASONE; LACTATE DEHYDROGENASE; ANTINEOPLASTIC AGENT;

BONE MARROW SUPPRESSION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOMA; MAJOR CLINICAL STUDY; ADULT; ARTICLE; BONE MARROW DISEASE; DRUG SCREENING; IATROGENIC DISEASE; MULTIPLE ORGAN FAILURE; NEUROLOGIC DISEASE; PATHOLOGY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW DISEASES; CISPLATIN; CYTARABINE; DEXAMETHASONE; DRUG EVALUATION; HUMAN; LYMPHOMA; MIDDLE AGE; MULTIPLE ORGAN FAILURE; NERVOUS SYSTEM DISEASES;

EID: 0023818185     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v71.1.117.bloodjournal711117     Document Type: Article

References (0)